#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Severe myoclonic epilepsy of infancy Autoimmune haemolytic anaemia Ovarian cancer stage IV Mixed-type liposarcoma Thalassaemia beta Non-Hodgkin's lymphoma refractory Adenocarcinoma pancreas Superficial vein thrombosis Acquired haemophilia Congenital myopathy Fungal infection Neuroendocrine carcinoma Inflammatory myofibroblastic tumour Leiomyosarcoma Cutaneous T-cell lymphoma stage II More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Life with Disease Synovial sarcoma metastatic – Diagnostics Hereditary motor and sensory neuropathy – Life with Disease Von Willebrand’s disease – Basic Information Burkitt’s lymphoma – Diagnostics Retinoblastoma Prader-Willi syndrome – Diagnostics Short-bowel syndrome – Basic Information Ehlers-Danlos syndrome – Treatment Congenital nephrogenic diabetes insipidus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mexiletine Levosimendan Emapalumab Mycophenolate Mofetil Intestifix Tianeptine Sodium Livmoniplimab Digoxin Sitravatinib Malate Crovalimab Leflunomide Nelivaptan Diacerein Gabapentin Mb-Cart20.1 Pimavanserin Tartrate Alxn2220 Dinoprostone Macrogol 3350 Gsk4011499 More therapies…

    Learn about Your Condition

    High-grade B-cell lymphoma Choroidal neovascularisation Morning sickness Gastrectomy Fatty acid oxidation disorder Pituitary tumour benign Depression Muscle injury Breast cancer stage III Arrhythmia supraventricular Thrombocytopenia Pancreatic carcinoma recurrent Biotinidase deficiency Chronic coronary syndrome Pneumothorax More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Prednisolone for Treating Acute Interstitial Nephritis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tubulointerstitial nephritis
    Investigated Drugs:
    • Prednisolone
    Denmark
  • Study on the Safety and Effects of NTRX-07 for Patients with Mild Cognitive Impairment or Mild to Moderate Alzheimer’s Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (3-BENZYL-3-METHYL-2,3-DIHYDROBENZOFURAN-6- YL)(PIPERIDIN-1-YL)METHANONE
    Czechia Hungary Poland
  • Study on the Effects of Mirtazapine for Improving Symptoms in Patients with Rett Syndrome

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rett syndrome
    Investigated Drugs:
    • Mirtazapine
    Italy
  • Study of olaparib and chemotherapy combination in stage III breast cancer patients with HER2-negative, hormone receptor impaired or deficient disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Thiotepa
    • Capecitabine
    • Carboplatin
    France The Netherlands
  • Study on Human Albumin Solution and Ringer Lactate for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastases to peritoneum
    Investigated Drugs:
    • Human Albumin Solution
    • Mannitol
    France
  • Study on the Effectiveness of 10-1074-LS and Teropavimab in Controlling HIV in Patients with Early Stage HIV Infection

    Recruiting

    2 1 1
    Investigated Drugs:
    • 10-1074-Ls
    • Teropavimab
    • Sodium Chloride
    Belgium Denmark Germany The Netherlands Spain Sweden
Previous Page
1 … 273 274 275 276 277 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!